SLDB vs TGT · rev $8.1M vs P/E 17, rev $51.98B
Solid Biosciences LLC (SLDB) versus Target Corporation (TGT) — a side-by-side from cached financials, not a winner call.
Solid Biosciences LLC (SLDB) is a biotechnology company listed on US.
Target Corporation (TGT) is a discount stores company listed on NYSE. It is led by Michael J. Fiddelke.
Latest reported SLDB revenue for 2022-12-31 was $8.1M. Net income was -$86.0M. SLDB currently screens at market cap $389.9M.
Latest reported TGT revenue for 2026-08-01 was $51.98B. Net income was $2.66B. TGT currently screens at market cap $58.05B and trailing P/E 16.9.
SLDB currently screens at market cap $389.9M. TGT currently screens at market cap $58.05B and trailing P/E 16.9.
Not investment advice. Open the SLDB and TGT stock pages for the full models.
Not investment advice.